STK11 Antibody

ArtNr	E10-30139
Hersteller	Enogene
Menge	100 ug/100 ul
Quantity options	100 ug/100 ul 100 ug/100 ul 200 ul 100 ul
Kategorie	Oncology Antibodies By Cell Type Carcinoma Hematology Lymphoma Myeloma Sarcoma Adenocarcinoma Flow Cytometry Western Blot ELISA Primary Antibodies
Typ	Antibody
Format	Liquid
Applikationen	WB, FC, ELISA
Specific against	Human (Homo sapiens), Mouse (Murine, Mus musculus), Monkey (Cynomolgus, Simian)
Host	Mouse
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	PJS, LKB1, STK11
Similar products	STK11
Lieferbar
Manufacturer - Applications	WB, FC, ELISA. Not yet tested in other applications.
Manufacturer - Conjugate / Tag	This antibody is also available with the following conjugates: AF350, AF405L, AF405M, AF405S, AF488, AF514, AF532, AF546, AF555, AF568, AF594, AF610, AF635, AF647, AF680, AF700, AF750, AF790, APC, AP, Biotin, Cy3, Cy5.5, Cy5, Cy7, FITC, HRP, PE, Magnetic beads (1 um, 2.8 um, 3 um, 4.5 um, 5 um, 10 um, 15 um, 20 um, 30 um, or different size option) Please contact sales@hoelzel.de for pricing and availability.
Storage Conditions	Store at 4C, for long term storage, store at -20C.
Molecular Weight	54kDa
Immunogen	Purified recombinant fragment of human STK11 expressed in E. Coli.
Research Area	Autophagy antibody, Cancer, Cardiovascular, Cell Biology, Epigenetics and Nuclear Signaling, Developmental Biologys, Immunology, Drug Discovery Products, Metabolism, Neuroscience, Signal Transduction, Stem Cells
Background	Essential role in G1 cell cycle arrest. Phosphorylates and activates members of the AMPK-related subfamily of protein kinases. Tumor suppressor.serine/threonine kinase 11, with two alternatively spliced isoforms, expressed in all tissues, strongly homolog of Xenopus early embryonic kinase 1 (XEEK1), tumor suppressor gene in hamartomas syndrome and in left sided colon carcinogenesis, mutated in sporadic testicular cancer, malignant melanomas and laryngeal tumors, playing a minor role in the development of ovarian carcinoma.LKB1 is a potential target for atherosclerosis and cancer and is shown to be mutated in patients with Peutz-Jeghers cancer syndrome. Tissue specificity: Ubiquitously expressed. Strongest expression in testis and fetal liver.
Recommended Dilutions	WB: 1/500 - 1/2000, FC: 1/200-1/400, ELISA: Propose dilution 1/10000.
Formulation Description	Ascitic fluid containing 0.03% sodium azide.
CiteID	EN0013816

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

E10-30139-datasheet.pdf

Sicherheitsdatenblatt anfordern

Einfache Bestellung Periodische Bestellung

Menge: 100 ug/100 ul

lieferbar

Lieferung vsl. bis 26.02.2026

Express-Lieferung: 23 Tage sparen

Vergleichen

Auf den Wunschzettel

Angebot anfordern